Science
Vivek Subbiah, Future of Cancer Treatment
Vivek Subbiah/LinkedIn

Vivek Subbiah: How Aggressive Brain Tumors Exploit Glucose to Suppress Normal Activity

Vivek Subbiah, Chief, Early-Phase Drug Development at Sarah Cannon Research Institute, shared on LinkedIn:

“Interesting paper published in Nature shows.

How aggressive brain tumours exploit glucose to suppress normal physiological activity in favour of malignant expansion and offer potential therapeutic strategies to enhance treatment outcomes.”

Title: Rewiring of cortical glucose metabolism fuels human brain cancer growth

Authors: Andrew J. Scott, Anjali Mittal, Baharan Meghdadi, Alexandra O’Brien, Justine Bailleul, Palavalasa Sravya, Abhinav Achreja, Weihua Zhou, Jie Xu, Angelica Lin, Kari Wilder-Romans, Ningning Liang, Ayesha U. Kothari, Navyateja Korimerla, Donna M. Edwards, Zhe Wu, Jiane Feng, Sophia Su, Li Zhang, Peter Sajjakulnukit, Anthony C. Andren, Junyoung O. Park, Johanna ten Hoeve, Vijay Tarnal, Daniel R. Wahl

Read The Full Article at Nature.

Vivek Subbiah: How Aggressive Brain Tumors Exploit Glucose to Suppress Normal Activity

See more articles about Vivek Subbiah.

Abhinav Achreja Alexandra O’Brien Andrew J. Scott Angelica Lin Anjali Mittal Anthony C. Andren Ayesha U. Kothari Baharan Meghdadi cancer Daniel R. Wahl Donna M. Edwards Jiane Feng Jie Xu Johanna ten Hoeve Junyoung O. Park Justine Bailleul Kari Wilder-Romans Li Zhang Nature Navyateja Korimerla Ningning Liang OncoDaily Oncology Palavalasa Sravya Peter Sajjakulnukit Sophia Su Vijay Tarnal Vivek Subbiah Weihua Zhou Zhe Wu